Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: An ITMO group study-Reference-Cited by-同舟云学术

Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: An ITMO group study

Published:2014-04-18 Issue:16 Volume:120 Page:2457-2463
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Bajetta Emilio¹,Catena Laura¹,Fazio Nicola²,Pusceddu Sara³,Biondani Pamela³,Blanco Giusi⁴,Ricci Sergio⁵,Aieta Michele⁶,Pucci Francesca⁷,Valente Monica⁸,Bianco Nadia¹,Mauri Chiara Maria¹,Spada Francesca²

Affiliation:

1. Institute of Oncology; Polyclinic Hospital; Monza Italy

2. Gastrointestinal and Neuroendocrine Tumors Unit; European Institute of Oncology; Milano Italy

3. Medical Oncology Unit; IRCCS Foundation National Cancer Institute; Milano Italy

4. Medical Oncology Unit; Mediterranean Institute of Oncology; Catania Italy

5. Medical Oncology Unit; S. Chiara Hospital; Pisa Italy

6. Medical Oncology Unit; Regional Oncology Hospital; Rionero in Vulture Italy

7. Medical Oncology Unit; University Hospital; Parma Italy

8. Medical Oncology Unit; Misericordia Hospital; Grosseto Italy

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28726/fullpdf

Reference35 articles.

1. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities;Swarts;Biochim Biophys Acta,2012

2. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States;Yao;J Clin Oncol,2008

3. Pancreatic neuroendocrine tumors: the impact of surgical resection on survival;Hill;Cancer,2009

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic treatment for neuroendocrine non-small cell lung carcinoma: A cases series and a systematic review of the literature;Lung Cancer;2023-07

2. Targeting neuroendocrine tumors with octreotide and lanreotide: Key points for clinical practice from NET specialists;Cancer Treatment Reviews;2023-06

3. Everolimus in combination with octreotide LAR in thymic atypical carcinoid;Thoracic Cancer;2023-04-10

4. Genetics of Pancreatic Neuroendocrine Tumors;Hematology/Oncology Clinics of North America;2022-10

5. Therapeutic strategies for patients with neuroendocrine neoplasms: current perspectives;Expert Review of Endocrinology & Metabolism;2022-07-13